Recently approved drugs for the treatment of multiple myeloma
Practical intricacies surrounding biosimilar adoption
Key misconceptions about biosimilars
Won Seog Kim
Exciting insights into the role of ROR1 in CLL
What impact do side effects have on elderly chronic myeloid leukemia (CML) patients?